GreenLight Biosciences

Biotechnology
$151.3Mtotal raised · 4 rounds on record
$102.5Mlatest round · Venture round · Jun 2020 · 6 yr ago
5backers · Future Ventures, Horizon Technology Finance
$174kgrants · 1 grant · CORDIS

Overview

Nature's Superpower. We must grow more food with the same amount of land while honoring the need and demands to replace chemical pesticides. Even as many pesticides face increasing consumer opposition – and threat of outright bans – due to environmental damage, many are losing their effectiveness.

Key facts

These are the key facts about GreenLight Biosciences on Alion as of Nov 13, 2026. GreenLight Biosciences is headquartered in Medford, United States. It has raised $151.3M in 3 funding rounds. The latest round is Venture - Series Unknown of $102.5M, announced in 2020.

Headquarters
Medford, United StatesAlion company profile, updated Nov 7, 2026
Employees
200+Alion company profile, an estimated range
Total raised
$151.3MSum of 3 equity rounds Alion knows
Latest round
Venture - Series Unknown · $102.5M · Jun 15, 2020SEC Form D filing · sec.gov
Visa sponsorship, United States
4 ▲ 300% · H-1B filings in 12 monthsUS Department of Labor · latest filing Jun 8, 2026

Funding and backers

Total raised
$151.3M
4 rounds on record
Latest round
$102.5M
Venture round · Jun 2020 · 6 yr ago
Team
141
US Form 5500 (plan participants) · Jun 2025
Grants
$174k
1 grant · CORDIS
Backers
5
Future Ventures, Horizon Technology Finance
The money's age
Long since its last round
76 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 15, 2024 Won a grant $174k · CORDIS Jun 15, 2020 Raised a round Venture round $102.5M · SEC Form D Dec 7, 2018 Raised a round Venture round $38.7M · SEC Form D Aug 31, 2017 Raised a round Venture round $10M · SEC Form D
Funding rounds
RoundDateAmountInvestorsSource
Grant Mar 2024 $174k — CORDIS
Venture round Jun 2020 $102.5M — SEC Form D
Venture round Dec 2018 $38.7M — SEC Form D
Venture round Aug 2017 $10M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Greenlight Biosciences Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Andrey ZarurExecutive Officer, DirectorSEC Form D
Marta Ortega-ValleExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Future Ventures fund Horizon Technology Finance fund Lewis & Clark Ventures fund Prelude Ventures fund S2G Investments fund
Investors in similar startupsfunds that back the companies most like this one
Y Combinator
backs ACX
Similar startupsby what they do, their industry and backers
ACX11-50 employees
ACX is pioneering sustainable agriculture through innovative biocides that replace chemical pesticides.

Visa sponsorship

#2,944 of 8,998 sponsors
United StatesUS 4
4 ▲ 300%
H-1B filings in 12 months
$93k
Median offered salary
0
Open roles in United States
Who they sponsor
Soil and plant scientists
1
Zoologists and wildlife biologists
1
Bioengineers and biomedical engineers
1
1 more occupations and the salary for eachVisa pass · 90 credits
In the register as GreenLight Biosciences, Inc., Medford, MA
Other sponsors in the same field
Daiichi Sankyo 28 filingsDechert 19 filingsKashiv Biosciences 17 filingsAvaya 15 filings
Alert me
US Department of Labor · latest filing Jun 8, 2026 · Visa details by country

Financials

Total raised
$151.5M
Latest round
Grant
Funding rounds
4
Funding rounds
Round Announced Amount
Grant 2024 $174k Details
Venture - Series Unknown 2020 $102.5M Details
Venture - Series Unknown 2018 $38.7M Details
Venture - Series Unknown 2017 $10M Details

People

Andrey Zarur
Executive Officer, Director
SEC Form D
Marta Ortega-Valle
Executive Officer
SEC Form D
Charles Cooney
Director
SEC Form D
Neil Renninger
Director
SEC Form D
James Swartz
Director
SEC Form D
Eric O'Brien
Director
SEC Form D
Ganesh Kishore
Director
SEC Form D
Jonathan Fleming
Director
SEC Form D
David Furneaux
Director
SEC Form D
Matthew Walker
Director
SEC Form D
Martha Schlicher
Director
SEC Form D
Michael Liang
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors5
Prelude VenturesVia a fund
13 portfolio companies: Ginkgo Bioworks, Powerhive, unspun and 10 more
Lewis & Clark VenturesVia a fund
19 portfolio companies: TomoCredit, Summersalt, Waldo Photos and 16 more
Future VenturesVia a fund
51 portfolio companies: The Boring Company, Prellis Biologics, Sanmai Technologies and 48 more
S2G InvestmentsVia a fund
96 portfolio companies: Terramera, SWARM, Datalecltd and 93 more
Horizon Technology FinanceVia a fund
153 portfolio companies: New York Stock Exchange - An Ice Exchange, Small Business Investor Alliance, DIANA STUTZ DESIGN and 150 more
Show all 5
Report a mistake

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Medford United States
HQ
200-500 est. staff

How to cite this page

Alion, "GreenLight Biosciences: key facts", as of Nov 13, 2026. https://alion.io/company/greenlightbiosciences

These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0